← Back to Search

Other

Plasma Transfusion for Aging (RESET-YOUTH Trial)

Phase 1 & 2
Waitlist Available
Led By Chandra s duggirala
Research Sponsored by Chandra Duggirala
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 40.
Stable medications for 2 months prior to Screening.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline,1,2,3,4,5,6, and 9 months.
Awards & highlights

RESET-YOUTH Trial Summary

This trial is studying whether monthly transfusions of young healthy male donor plasma can help improve cognitive, renal, and pulmonary function, and muscle strength, as well as changes in biological age as assessed by DNA methylation levels.

RESET-YOUTH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

RESET-YOUTH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline,1,2,3,4,5,6, and 9 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline,1,2,3,4,5,6, and 9 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biological age as assessed by DNA methylation levels, to calculate the Epigenetic age.
Secondary outcome measures
DHEAS
Estrogen
High Sensitivity C-Reactive Protein
+8 more
Other outcome measures
Exploratory biomarkers

RESET-YOUTH Trial Design

1Treatment groups
Experimental Treatment
Group I: Plasma TransfusionExperimental Treatment1 Intervention
Plasma Transfusions with 2 units of plasma per dose, for a total of 6 doses

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Chandra DuggiralaLead Sponsor
Chandra s duggiralaPrincipal InvestigatorFountain Labs, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has this clinical trial opened its doors to new participants?

"According to clinicaltrials.gov, this medical study has concluded recruitment with the most recent update issued on January 14th 2018. However, there are currently 245 other studies actively enrolling patients at this juncture."

Answered by AI
~310 spots leftby Mar 2025